- Sections
- C - Chimiemétallurgie
- C12N - Micro-organismes ou enzymescompositions les contenantculture ou conservation de micro-organismestechniques de mutation ou de génétiquemilieux de culture
- C12N 15/18 - Hormones de croissance
Détention brevets de la classe C12N 15/18
Brevets de cette classe: 120
Historique des publications depuis 10 ans
|
1
|
1
|
2
|
3
|
3
|
4
|
4
|
1
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Opko Biologics Ltd. | 78 |
8 |
| Florida State University Research Foundation, Inc. | 784 |
4 |
| Pfizer Inc. | 3400 |
3 |
| National Research Council of Canada | 1569 |
3 |
| Novagen Holding Corporation | 25 |
3 |
| Regeneron Pharmaceuticals, Inc. | 4448 |
3 |
| Genentech, Inc. | 4005 |
2 |
| Wyeth LLC | 649 |
2 |
| Amgen Inc. | 4268 |
2 |
| The Trustees of Columbia University in the City of New York | 3597 |
2 |
| Acceleron Pharma Inc. | 351 |
2 |
| Ambrx, Inc. | 168 |
2 |
| The Governors of the University of Alberta | 876 |
2 |
| Institute for Research in Biomedicine (IRB) | 40 |
2 |
| Minerva Biotechnologies Corporation | 112 |
2 |
| Ottawa Hospital Research Institute | 108 |
2 |
| The Regents of the University of Colorado, a body corporate | 2733 |
2 |
| Transalgae Israel Ltd. | 14 |
2 |
| United Therapeutics Corporation | 313 |
2 |
| Yale University | 2447 |
2 |
| Autres propriétaires | 68 |